Back Login for AI Analysis

    TSHA (STOCKS)

    Taysha Gene Therapies, Inc. Common Stock

    $4.660000
    +0.000000 (+0.00%)
    Prev close: $4.660000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Sean P. Nolan
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $1,272.36M
    Employees
    73
    P/E (TTM)
    -13.12
    P/B (TTM)
    5.83
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Analyst Recommendations
    6
    Strong Buy
    13
    Buy
    1
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Sep 2025 (Q3)
    		 $-0.09 $-0.09 +0.0000 +0.00%
    Jun 2025 (Q2)
    		 $-0.09 $-0.08 -0.0075 -9.09%
    Mar 2025 (Q1)
    		 $-0.08 $-0.09 +0.0144 +15.25%
    Dec 2024 (Q4)
    		 $-0.07 $-0.08 +0.0147 +17.36%
    Financial Statements
    TTM (Sep 2025)
    Revenues $6.31M
    Benefits Costs and Expenses $106.24M
    Costs And Expenses $106.24M
    Nonoperating Income/Loss $2.20M
    Operating Expenses $108.44M
    Research and Development $76.78M
    Other Operating Expenses $31.66M
    Operating Income/Loss -$102.13M
    Income/Loss From Continuing Operations After Tax -$99.93M
    Income/Loss From Continuing Operations Before Tax -$99.93M
    Income Tax Expense/Benefit $0.00
    Net Income/Loss -$99.93M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$99.93M
    Net Income/Loss Available To Common Stockholders, Basic -$99.93M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$0.33
    Diluted Earnings Per Share -$0.33
    Basic Average Shares 643,118,776
    Diluted Average Shares 643,118,776
    Assets $316.55M
    Current Assets $299.95M
    Noncurrent Assets $16.60M
    Fixed Assets $6.81M
    Other Non-current Assets $9.80M
    Liabilities $97.57M
    Current Liabilities $28.63M
    Accounts Payable $5.44M
    Wages $5.35M
    Other Current Liabilities $17.85M
    Noncurrent Liabilities $68.93M
    Equity $218.99M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $218.99M
    Liabilities And Equity $316.55M
    Net Cash Flow From Operating Activities -$84.68M
    Net Cash Flow From Operating Activities, Continuing -$84.68M
    Net Cash Flow From Investing Activities -$344.00K
    Net Cash Flow From Investing Activities, Continuing -$344.00K
    Net Cash Flow From Financing Activities $224.68M
    Net Cash Flow From Financing Activities, Continuing $224.68M
    Net Cash Flow $139.66M
    Net Cash Flow, Continuing $139.66M
    Comprehensive Income/Loss -$98.74M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$98.74M
    Other Comprehensive Income/Loss $1.19M
    Related Companies
    HHH